Skip to main content
Top
Published in: Tumor Biology 7/2014

01-07-2014 | Research Article

Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity

Authors: Fengqing Hu, Zhen Tao, Zhenya Shen, Xiaolin Wang, Fei Hua

Published in: Tumor Biology | Issue 7/2014

Login to get access

Abstract

Eph/ephrin signaling system plays a very important role in the tumorigenesis and the formation of blood vessel. However, the function of EphB4 and its ligand ephrin B2 in the carcinogenesis of esophageal squamous cell carcinoma (ESCC) is not fully understood. Here, it was found that the expression of EphB4 was up-regulated in ESCC tissues compared with the paired normal tissues, while ephrin B2 was down-regulated in ESCC samples. Phosphorylation of EphB4 induced by its ligand ephrin B2-Fc inhibited the growth, migration and colony formation of ESCC cells. Moreover, over-expression of EphB4 or EphB4 kinase dead mutant (EphB4 KD) in ESCC cells promoted cell growth and migration, suggesting EphB4 promoted cell growth and migration independent of its kinase activity. Furthermore, we found that EphB4 interacted with the adaptor protein RACK1 and RACK1 decreased the phosphorylation level of EphB4. Taken together, our study revealed the important function and regulation of EphB4 in the progression of ESCC and suggested EphB4 as a novel target for the treatment of ESCC.
Literature
1.
go back to reference Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2012;60:277–300.CrossRef Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2012;60:277–300.CrossRef
3.
go back to reference Tachibana M, Kinugasa S, Yoshimura, et al. Extended esophagectomy with 3-field lymph node dissection for esophageal cancer. Arch Surg. 2003;138:1383–9.CrossRefPubMed Tachibana M, Kinugasa S, Yoshimura, et al. Extended esophagectomy with 3-field lymph node dissection for esophageal cancer. Arch Surg. 2003;138:1383–9.CrossRefPubMed
4.
go back to reference Kopreski MS, Witters L, Brennan WAJ, et al. Protein tyrosine kinase activity in breast cancer and its relation to prognostic indicators. Anticancer Res. 1996;16:3037–41.PubMed Kopreski MS, Witters L, Brennan WAJ, et al. Protein tyrosine kinase activity in breast cancer and its relation to prognostic indicators. Anticancer Res. 1996;16:3037–41.PubMed
5.
go back to reference Lindberg RA, Hunter T. cDNA cloning and characterization of eck, an epithelial cell receptor protein tyrosine kinase in the eph/elk family of protein kinase. Mol Cell Biol. 1990;10:6316–24.PubMedCentralPubMed Lindberg RA, Hunter T. cDNA cloning and characterization of eck, an epithelial cell receptor protein tyrosine kinase in the eph/elk family of protein kinase. Mol Cell Biol. 1990;10:6316–24.PubMedCentralPubMed
6.
go back to reference Surawska H, Ma PC, Salgia R. The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev. 2004;15:419–33.CrossRefPubMed Surawska H, Ma PC, Salgia R. The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev. 2004;15:419–33.CrossRefPubMed
7.
8.
go back to reference Bruhl T, Urbich C, Aicher D, et al. Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ Res. 2004;94:743–51.CrossRefPubMed Bruhl T, Urbich C, Aicher D, et al. Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ Res. 2004;94:743–51.CrossRefPubMed
9.
go back to reference Steinle JJ, Meininger CJ, Forough R, et al. EphB4 receptor signaling mediates endothelial cell migration and proliferation via PI3K pathway. J Biol Chem. 2002;277:43830–5.CrossRefPubMed Steinle JJ, Meininger CJ, Forough R, et al. EphB4 receptor signaling mediates endothelial cell migration and proliferation via PI3K pathway. J Biol Chem. 2002;277:43830–5.CrossRefPubMed
10.
go back to reference Hasina R, Mollberg N, Kawada I. Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers. Cancer Res. 2013;73:184–94.CrossRefPubMed Hasina R, Mollberg N, Kawada I. Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers. Cancer Res. 2013;73:184–94.CrossRefPubMed
11.
go back to reference Hu HQ, Tao Z, Wang MS, et al. RACK1 promoted the growth and migration of the cancer cells in the progression of esophageal squamous cell carcinoma. Tumor Biol. 2013;34:3893–9.CrossRef Hu HQ, Tao Z, Wang MS, et al. RACK1 promoted the growth and migration of the cancer cells in the progression of esophageal squamous cell carcinoma. Tumor Biol. 2013;34:3893–9.CrossRef
12.
go back to reference Xia G, Kumar SR, Masood R, et al. EphB4 expression and biological significance in prostate cancer. Cancer Res. 2005;65:4623–32.CrossRefPubMed Xia G, Kumar SR, Masood R, et al. EphB4 expression and biological significance in prostate cancer. Cancer Res. 2005;65:4623–32.CrossRefPubMed
13.
go back to reference Xia G, Kumar SR, Stein JP, et al. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene. 2006;25:769–80.CrossRefPubMed Xia G, Kumar SR, Stein JP, et al. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene. 2006;25:769–80.CrossRefPubMed
14.
go back to reference Kumar SR, Masood R, Spannuth WA, et al. The receptor tyrosine kinase Ephb4 is overexpressed in ovarian cancer, provides signals and predicts poor outcome. Br J Cancer. 2007;96:1083–91.PubMedCentralCrossRefPubMed Kumar SR, Masood R, Spannuth WA, et al. The receptor tyrosine kinase Ephb4 is overexpressed in ovarian cancer, provides signals and predicts poor outcome. Br J Cancer. 2007;96:1083–91.PubMedCentralCrossRefPubMed
15.
go back to reference Noren NK, Foos G, Hauser CA, et al. The EphB4 receptor suppresses breast cancer cell tumorigenecity through an Abl–Crk pathway. Nat Cell Biol. 2006;8:815–25.CrossRefPubMed Noren NK, Foos G, Hauser CA, et al. The EphB4 receptor suppresses breast cancer cell tumorigenecity through an Abl–Crk pathway. Nat Cell Biol. 2006;8:815–25.CrossRefPubMed
16.
go back to reference Deng YZ, Yao F, Li JJ, et al. RACK1 Suppresses gastric tumorigenesis by stabilizing beta-catenin destruction complex. Gastroenterology. 2012;142:812–23.CrossRefPubMed Deng YZ, Yao F, Li JJ, et al. RACK1 Suppresses gastric tumorigenesis by stabilizing beta-catenin destruction complex. Gastroenterology. 2012;142:812–23.CrossRefPubMed
17.
Metadata
Title
Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity
Authors
Fengqing Hu
Zhen Tao
Zhenya Shen
Xiaolin Wang
Fei Hua
Publication date
01-07-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 7/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-1955-4

Other articles of this Issue 7/2014

Tumor Biology 7/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine